The aim of this study is to evaluate the protective effect of nicorandil, a selective mitochondrial KATP channel opener, on QT prolongation and myocardial damage induced by amitriptyline. The dose of amitriptyline (intraperitoneal, i.p.) that prolong the QT interval was found 75 mg/kg. Rats were randomized into five groups the control group, amitriptyline group, nicorandil (selective mitochondrial KATP channel opener, 3 mg/kg i.p.) + amitriptyline group, 5-hdyroxydecanoate (5-HD, selective mitochondrial KATP channel blocker, 10 mg/kg i.p.) + amitriptyline group and 5-HD + nicorandil + amitriptyline group. Cardiac parameters, biochemical and histomorphological/immunohistochemical examinations were evaluated. p < 0.05 was accepted as statistically significant. Amitriptyline caused statistically significant prolongation of QRS duration, QT interval and QTc interval (p < 0.05). It also caused changes in tissue oxidant (increase in malondialdehyde)/anti-oxidant (decrease in glutathione peroxidase) parameters (p < 0.05), myocardial damage and apoptosis (p < 0.01 and p < 0.001). While nicorandil administration prevented amitriptyline-induced QRS, QT, QTc prolongation (p < 0.05), myocardial damage and apoptosis (p < 0.05), it did not affect the changes in oxidative parameters (p > 0.05). Our results suggest that nicorandil, a selective mitochondrial KATP channel opener, plays a protective role in amitriptyline-induced QT prolongation and myocardial damage. Mitochondrial KATP channel opening and anti-apoptotic effects may play a role in the cardioprotective effect of nicorandil.
27 May 2021 in Journal of Basic and Clinical Health Sciences
Purpose: The purpose of our study is to reveal the demographic features, exposure routes and reasons for exposure, clinical effects and outcomes of cardiovascular drug poisonings reported to the Dokuz Eylul University Drug and Poison Information Center (DEUDPIC) between January 2014 and December 2017. Methods: This retrospective, descriptive, and cross-sectional study was approved by the Noninvasive Research Ethics Committee of Dokuz Eylül University School of Medicine. All data were recorded on standard data forms and then transferred to a software (Ruber, written by Engin Yildiztepe, 2007) for data analysis. Results: There were 43 poisonings cases were reported with cardiovascular drugs. Female cases were common (60.47%). Half of the poisoning cases were toxic (51.16%). The most common reason of poisonings was intentional (81.40%). All of cases between 13-49 age group were intentional exposures. Only single substance intakes were responsible for the most of the drug exposures (62.79%). The most common agents were beta-blockers (29.85%), medicines that affect the renin-angiotensin system (23.88 %), calcium channel blockers (11.94%) and cardiac therapy drugs such as digoxin (11.94%). Clinical signs and symptoms were classified as asymptomatic (37.21%), mild (23.26%), moderate (23.26%), and severe (4.65%). Recommended treatments were observation and supportive care (46.67%), decontamination methods (44.00%) and antidote therapy (2.67%). One fatality was reported. Conclusions: We suggest that determination of the epidemiological characteristics of cardiovascular drug exposures in our country through prospectively multi-centered studies may provide significant contributions to prevent poisonings and decrease the mortality and morbidity of the cases.
Yasal ve yasadışı maddelere dair kullanım bozuklukları günümüzde toplumların önemli sorunları arasındadır. Teknoloji ile birlikte iletişim ve ulaşım alanlarındaki gelişim, kötüye kullanımı olan bu maddelerin çeşitliliğinin ve kullanımın artmasına dolayısıyla bu maddelerle ilgili sorunların karşımıza çıkmasına sebep olmuştur. Madde kullanımı, risk etmenleri bakımından tıbbi, adli, sosyal ve güvenlik boyutları ile değerlendirilmesi gereken bir konu halini almıştır.